Skip to content

8box Solutions Inc.

8box Sticky Header

RMC No. 131-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 131-2022 issued on September 28, 2022 announces the availability of Offline Electronic Bureau of Internal Revenue Forms (eBIRForms) Package Version 7.9.3, which is downloadable from www.bir.gov.ph and www.knowyourtaxes.ph/ebirforms.         

RMC No. 130-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 130-2022 issued on September 26, 2022 extends until September 27, 2022 the deadline for the eFiling/filing of returns (BIR Forms 2550M, 2550Q and 2551Q) and ePayment/payment of corresponding taxes due thereon as

RMC No. 129-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 129-2022 issued on September 20, 2022 publishes the September 1, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate endorsing updates to the “List of VAT-Exempt Medicines” under

RMC No. 128-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 128-2022 issued on September 7, 2022 notifies the loss of one (1) set of used/filled-up but unissued BIR Form No. 2313-R – Electronic Certification Authorizing Registration for transactions involving transfer of real

RMC No. 127-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 127-2022 issued on September 7, 2022 lifts and removes, effective immediately, the suspension and prohibition under Revenue Memorandum Circular No. 77-2022 on the following:         a. All field audit and

RMC No. 126-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 126-2022 issued on September 6, 2022 circularizes the Consolidated Price of Sugar at Millsite for the month of July 2022 contained in Operations Memorandum (OM) Nos. 58-2022, 59-2022, 62-2022, 63-2022 and 65-2022. 

RMC No. 125-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 125-2022 issued on September 6, 2022 publishes the August 17, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate, endorsing updates to the “List of VAT-Exempt Medicines” under

RMC No. 124-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 124-2022 issued on September 1, 2022 publishes the August 15, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate endorsing updates to the “List of VAT-Exempt Medicines” under

RMC No. 123-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 123-2022 issued on August 31, 2022 clarifies the provisions of Revenue Regulations (RR) No. 6-2022 relative to the removal of the five (5) – year validity period on receipts/invoices, which shall take

RMC No. 122-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 122-2022 issued on August 22, 2022 prescribes the guidelines in updating of registration information record of taxpayers who will enroll in the Bureau’s Online Registration and Update System (ORUS).